Mylan launches cheaper version of EpiPen allergy treatment

Mylan launches cheaper version of EpiPen allergy treatment


Drugmaker Mylan has started selling a generic version of its emergency allergy treatment EpiPen at half the price of the branded option, the cost of which drew national scorn and attracted Congressional inquiries. The launch of Mylan's long-promised generic alternative is expected to still generate millions of dollars in revenue for the drugmaker while also protecting its market share against current and future competition.



from Biotech News